Diffusion Pharmaceuticals Statistics Share Statistics Diffusion Pharmaceuticals has 2.04M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 2.04M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.35M Failed to Deliver (FTD) Shares 1,506 FTD / Avg. Volume 3.15%
Short Selling Information The latest short interest is 2.87K, so 0% of the outstanding
shares have been sold short.
Short Interest 2.87K Short % of Shares Out n/a Short % of Float 0.14% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -3.27 and the forward
PE ratio is null.
Diffusion Pharmaceuticals's PEG ratio is
0.
PE Ratio -3.27 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.36 P/FCF Ratio -3.22 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Diffusion Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 28.5,
with a Debt / Equity ratio of 0.
Current Ratio 28.5 Quick Ratio 28.5 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -33.33% in the
last 52 weeks. The beta is 1.76, so Diffusion Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.76 52-Week Price Change -33.33% 50-Day Moving Average 4.99 200-Day Moving Average 7.18 Relative Strength Index (RSI) 78.62 Average Volume (20 Days) 47,812
Income Statement
Revenue n/a Gross Profit n/a Operating Income -18.23M Net Income -16.29M EBITDA -18.23M EBIT n/a Earnings Per Share (EPS) -2.02
Full Income Statement Balance Sheet The company has 9M in cash and 0 in
debt, giving a net cash position of 9M.
Cash & Cash Equivalents 9M Total Debt n/a Net Cash n/a Retained Earnings -70.73M Total Assets 38.58M Working Capital 36.72M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.53M
and capital expenditures 0, giving a free cash flow of -16.53M.
Operating Cash Flow -16.53M Capital Expenditures n/a Free Cash Flow -16.53M FCF Per Share -2.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields DFFN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for DFFN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 17, 2023. It was a
backward
split with a ratio of 2:3.
Last Split Date Aug 17, 2023 Split Type backward Split Ratio 2:3
Scores Altman Z-Score -717.47 Piotroski F-Score 3
